Company / Interest Expense per Share
Revolution Medicines, Inc. Interest Expense per Share History
FY2018-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.00
FY2022
5-year range
$0.00 / $0.00
FY2018-FY2022
Trend
-39.8%
vs FY2021
Sector context
#38 of 43
Health Care
What the data says
Revolution Medicines, Inc.'s interest expense per share of $0.00 is lower than 88% of companies in the Health Care sector (FY2022). Interest Expense per Share has declined for 4 consecutive years, from $0.05 in FY2018 to $0.00 in FY2022.
Based on SEC 10-K filings.
0.00 in FY2022 with a 3-year CAGR of -70.7%.
Improved from $0.04 to $0.00 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -70.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-100.0% below sector average
Key checks
Key Insights
- Revolution Medicines, Inc.'s interest expense per share has declined for 4 consecutive years.
- In FY2022, interest expense per share decreased 39.8% year-over-year.
- Ranks #38 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $0.00 | -39.8% |
| FY2021 | $0.00 | -95.5% |
| FY2020 | $0.04 | -7.8% |
| FY2019 | $0.04 | -24.2% |
| FY2018 | $0.05 | - |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026